JPS6043073B2 - Method for producing cephalosporin compounds using new silylating agents - Google Patents
Method for producing cephalosporin compounds using new silylating agentsInfo
- Publication number
- JPS6043073B2 JPS6043073B2 JP56190944A JP19094481A JPS6043073B2 JP S6043073 B2 JPS6043073 B2 JP S6043073B2 JP 56190944 A JP56190944 A JP 56190944A JP 19094481 A JP19094481 A JP 19094481A JP S6043073 B2 JPS6043073 B2 JP S6043073B2
- Authority
- JP
- Japan
- Prior art keywords
- general formula
- acid
- tables
- compound
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Description
【発明の詳細な説明】
本発明は一般式(1)
で表わされる7−アミノデスアセトキシセフアロスポラ
ン酸をシリル化して一般式(■)の如きその酸のシリル
エステルを生成せしめついで一般式(■)〔ただしR1
およびR2は低級アルキル基である〕で表わされる混合
酸無水物と反応させ該化合物をアシル化した後脱シリル
化することによソー般式(■)で表わされるセフアロス
ポリン化合物の製造方法において、シリル化剤として一
般式(■)で表わされる新規な化合物、N,N−ジメチ
ルートリメチルシリルホルマジニウムクロライドを使用
することを特徴とする前記セフアロスポリン化合物の改
良された製造方法に関するものである。DETAILED DESCRIPTION OF THE INVENTION The present invention involves silylating 7-aminodesacetoxycephalosporanic acid represented by the general formula (1) to produce a silyl ester of the acid as represented by the general formula (■). ■) [However, R1
and R2 is a lower alkyl group], the compound is acylated, and then desilylated to produce a cephalosporin compound represented by the general formula (■). The present invention relates to an improved method for producing the cephalosporin compound, characterized in that a novel compound represented by the general formula (■), N,N-dimethyl-trimethylsilylforminium chloride, is used as a curing agent.
従来セフアロスポリン抗生物質を製造するには種々の公
知の方法があるが、その中の中代表的な幾つかの例を示
せば7−アミノデスアセトキシセフアロスポラン酸また
は7−アミノセフアロスポラン酸にヘキサメチルジシラ
ザンを用いてシリル化させる方法あるいはビス−トリメ
チルシリル尿素またはビス−トリメチルシリルアセトア
ミドを用いてシリル化させる方法があり、これらがもつ
ぱら用いられてきた。これらの方法はしかしながら、い
づれも高価なシリル化剤を用いる必要があり、しかも高
温度の条件下に高沸点溶媒を用いて還流操作を行うので
、7−アミノデスアセトキシセフアロスポラン酸が分解
する傾向があり、また反応後、反応溶媒を新しく取換え
るための余分な操作が必要になるlなど難点があり、製
品原価の上昇を免れるこができなかつた。There are various known methods for producing cephalosporin antibiotics, and some representative examples include 7-aminodesacetoxycephalosporanic acid or 7-aminocephalosporanic acid. There is a method of silylation using hexamethyldisilazane or a method of silylation using bis-trimethylsilylurea or bis-trimethylsilylacetamide, and these methods have been widely used. However, all of these methods require the use of expensive silylating agents, and the reflux operation is performed under high temperature conditions using a high-boiling point solvent, resulting in the decomposition of 7-aminodesacetoxycephalosporanic acid. However, there are also disadvantages such as the need for extra operations to replace the reaction solvent after the reaction, resulting in an increase in the cost of the product.
上記の方法とは別に、シリル化剤としてトリメチルクロ
ロシランを用いてシリル化させる方法もあるが、この方
法ではトリエチルアミンなどの有,機塩基を使用しなけ
ればならないし、さらになお一層過酷な反応条件も必要
となり、しかもシリル化率は期待しうるほど反応性が見
られないので利点があるとはいえない。Apart from the above method, there is also a method of silylation using trimethylchlorosilane as a silylating agent, but this method requires the use of an organic base such as triethylamine and requires even more severe reaction conditions. However, since the silylation rate is not as reactive as expected, it cannot be said that there is any advantage.
本発明では上述の従来公知の方法に見られるよ;うな難
点のすべてを克服し、進歩、改良した技術的方法を新し
く提供するために、シリル化剤として新しく一般式(V
)で表わされるN,N−ジメチルートリメチルシリルホ
ルマミジニウムクロライドを利用することを意図するも
のである。In the present invention, in order to overcome all the difficulties found in the above-mentioned conventionally known methods and to provide a new, advanced and improved technical method, a new silylating agent of the general formula (V
) is intended to utilize N,N-dimethyl-trimethylsilylformamidinium chloride.
本発明のこの新規なシリル化剤を使用すれば、極性溶媒
中で20〜50℃の反応温度において極めて容易に7−
アミノデスアセトキシセポラン酸や7−アミノセフアロ
スポラン酸をシリル化することができる。今参考のため
にセフアロスポリン化合物の製造に関する公知の技術に
ついて記述すると、米国特許第3985741号では7
−アミノデスアセトキシセフアロスポラン酸を水とアセ
トン溶媒中にトリエチルアミンとともに溶解させた後、
D−N−(2−メトキシカルボニルー1−メチルビニル
)−α.アミノーα−(4−ヒドロキシフェニル)酢酸
ナトリウムと反応させセフアロスポリン化合物を低収率
で得ている。Using this novel silylating agent of the present invention, 7-
Aminodesacetoxyseporanic acid and 7-aminocephalosporanic acid can be silylated. For now reference, the known techniques for the production of cephalosporin compounds are described in U.S. Pat. No. 3,985,741
- After dissolving aminodesacetoxycephalosporanic acid in water and acetone solvent with triethylamine,
D-N-(2-methoxycarbonyl-1-methylvinyl)-α. A cephalosporin compound is obtained in low yield by reaction with sodium amino-α-(4-hydroxyphenyl)acetate.
英国特許第1240687号では7−アミノデスアセト
キシセフアロスポラン酸を炭酸ナトリウム水溶液に溶解
した後、得られるそのナトリウム塩を、D−(−)−α
−(p−ヒドロキシフェニル)−α−(t−ブトキシカ
ルボニルアミノ)酢酸の2,6−ルチジン塩をアルキル
ハロホルメートと反応して得られる酸無水物でアシル化
することにより該当するセフアロスポリン化合物を製造
している。しかしこの方法はアシル化工程が複雑なため
に製造条件が不利であり、収得率は低くなる。さらに米
国特許第4160863号では7−アミノデスアセトキ
シセフアロスポラン酸をヘキサメチルジシラザンを使用
してシリル化し、D−p−ヒドロキシフェニルグリシル
クロライド塩酸ヘミジオキサンと反応させてセフアロス
ポリン化合物を製造する例が報告されいる。British Patent No. 1240687 discloses that after dissolving 7-aminodesacetoxycephalosporanic acid in an aqueous sodium carbonate solution, the resulting sodium salt is D-(-)-α
The corresponding cephalosporin compound is obtained by acylating the 2,6-lutidine salt of -(p-hydroxyphenyl)-α-(t-butoxycarbonylamino)acetic acid with an acid anhydride obtained by reacting with an alkyl haloformate. Manufactured. However, this method has disadvantageous manufacturing conditions due to the complicated acylation step, resulting in a low yield. Further, in U.S. Pat. No. 4,160,863, 7-aminodesacetoxycephalosporanic acid is silylated using hexamethyldisilazane and reacted with D-p-hydroxyphenylglycyl chloride hydrochloride hemidioxane to produce a cephalosporin compound. is reported.
これらの技術では、いづれも7−アミノデスアセトキシ
セフアロスポラン酸を次の一般式(■)
〔ただしR″はアルカリ金属Na,KまたはR3NH2
(ただしR3は低級アルキル基である)または−Si(
CH3)3である〕の如く、その無機塩としてカルボキ
シル基を保護するか、有機アミンと結合させて有機アミ
ン塩とし、あるいはシリル化剤であるヘキサメチルジシ
ラザン、ビス−トリメチルシリルアセトアミド、ビス−
トリメチルシリル尿素または有機アミン存在の下でのト
リメチルクロロシランとの反応によ゛りシリル化してカ
ルボキシル基を保護した後、一般式(■)および一般式
(■)
〔ただしR4はアルカリ金属NaまたはKであり、R5
はメチルまたはエチル基である〕で表わされるp−ヒド
ロキシフェニルグリシンの活性化体と反応させ該当する
セフアロスポリン化合物を製造するものであつた。In all of these techniques, 7-aminodesacetoxycephalosporanic acid is converted to the following general formula (■) [where R'' is an alkali metal Na, K or R3NH2
(However, R3 is a lower alkyl group) or -Si(
CH3)3], protect the carboxyl group as an inorganic salt, or combine it with an organic amine to form an organic amine salt, or use the silylating agents hexamethyldisilazane, bis-trimethylsilylacetamide, bis-
After protecting the carboxyl group by silylation by reaction with trimethylsilyl urea or trimethylchlorosilane in the presence of an organic amine, the general formula (■) and the general formula (■) [However, R4 is an alkali metal Na or K] Yes, R5
is a methyl or ethyl group] to produce the corresponding cephalosporin compound.
本発明では7−アミノデスアセトキシセフアロスポラン
酸を新規なシリル化剤N,N−ジメチルーートリメチル
シリルホルマミジニウムクロライドを使用し20〜50
℃で極性溶媒中で反応させると容易にシリル化すること
ができるからかくして得られた一般式(■)として先に
示したシリル化物を一般式(■)として同じく先に示し
た酸無水物と反応させてアシル化し、次に加水分解して
シリル基及びアミノ基の保護基を除き、得られる粗製物
をさらに有機溶媒中で精製することにより、一般式(■
)て表わされる目的化合物を高収率かつ高純度で得るこ
とができる。In the present invention, 7-aminodesacetoxycephalosporanic acid is converted to 20 to 50
Since it can be easily silylated by reacting in a polar solvent at ℃, the silylated product shown above as the general formula (■) obtained in this way can be combined with the acid anhydride also shown above as the general formula (■). By reacting to acylate, then hydrolyzing to remove the protecting groups of the silyl and amino groups, and further purifying the resulting crude product in an organic solvent, the general formula (■
) can be obtained in high yield and purity.
次に本発明の方法をさらに詳しく説明するために実施例
を示す。Next, Examples will be shown to explain the method of the present invention in more detail.
実施例1
100m1のアセトニトリル中に36.5グラム(0.
2モル)のN,N−ジメチルートリメチルシリルホルマ
ミジニウムクロライドを溶かした溶液に20グラム(イ
).093モル)の7−アミノデスアセトキシセフアロ
スポラン酸を加えて徐々に温度を上げ最高50℃を維持
しつつ攪拌を続けるとシリル化が進行し溶液は清澄とな
る。Example 1 36.5 grams (0.
2 mol) of N,N-dimethyl-trimethylsilylformamidinium chloride was dissolved in a solution containing 20 grams (A). 093 mol) of 7-aminodesacetoxycephalosporanic acid was added, the temperature was gradually raised, and stirring was continued while maintaining a maximum of 50°C. As a result, silylation progressed and the solution became clear.
上記溶液は0℃に冷却しておく一方、別の反応容器に5
0m1のアセトニトリルと100w1.1(7)N,N
−ジメチルホルムアシドを入れ、これに10m1(7)
N,.N−ジメチルベンジルアミンを加えて−30℃に
冷却した後、13m1のエチルクロロホルムメートを加
える。While the above solution was cooled to 0°C, it was placed in a separate reaction vessel for 5 min.
0ml of acetonitrile and 100w1.1(7)N,N
- Add dimethylformacide and add 10ml (7)
N,. After adding N-dimethylbenzylamine and cooling to −30° C., 13 ml of ethyl chloroformate are added.
これにつづいて速に35グラムのD−N一(2−エトキ
シカルボニルー1−メチルビニル)一α−アミノーα一
(4−ヒドロキシフェニル)=酢酸を加えて反応させる
。3紛間同一温度で攪拌をつづけた後、前記の冷却して
おいてシリル化7−アミノデスアセトキシセフアロスポ
ラン酸溶液を、低温−30℃を維持しつつ1時間に亘つ
て加え、さらにピリジンを徐々に加えPHを5〜6に調
り節する。Following this, 35 grams of DN-(2-ethoxycarbonyl-1-methylvinyl)-α-amino-α-(4-hydroxyphenyl)-acetic acid was immediately added and allowed to react. After stirring the three powders at the same temperature, the cooled silylated 7-aminodesacetoxycephalosporanic acid solution was added over 1 hour while maintaining the low temperature of -30°C, and then pyridine was added. Gradually add to adjust the pH to 5-6.
同一温度でさらに2時間反応させ水を加えると清澄な溶
液となるのでなお1時間攪拌後300m1のアセトニト
リルを添加し以後1晩攪拌する。沈殿生成物を枦過し、
アセトニトリルで洗つてから65%アセトニトリル水溶
液中に分散させ20〜30℃で3紛間攪拌後淵過して乾
燥すれば目的化合物7−〔D−α−アミノー2−(4−
ヒドロキシフェニル)アセタミド〕−デスアセトキシセ
フアロスポラン酸25グラムが得られる。このものは薄
層クロマトグラフィ(Rf=0.28、シリカゲル60
被覆板)および化学分析(含量930rr1cg/Mg
、水分4.5%、酸度4.8.比旋光度十161r(1
%、H2O)、酸含量99。After reacting for another 2 hours at the same temperature and adding water, a clear solution was obtained. After stirring for another 1 hour, 300 ml of acetonitrile was added and the mixture was stirred overnight. filtering the precipitated product;
Washing with acetonitrile, dispersing in 65% acetonitrile aqueous solution, stirring at 20-30°C, filtering and drying yields the target compound 7-[D-α-amino-2-(4-
25 grams of hydroxyphenyl)acetamide]-desacetoxycephalosporanic acid are obtained. This product is used for thin layer chromatography (Rf=0.28, silica gel 60
coating plate) and chemical analysis (content 930rr1cg/Mg
, moisture 4.5%, acidity 4.8. Specific optical rotation 1161r (1
%, H2O), acid content 99.
4%、塩基含量99.6%)により目的化合物であるこ
とが確認された。4%, base content 99.6%), it was confirmed to be the target compound.
実施例2
実施例1と同様の操作により、32グラムのD−N−(
2−メトキシカルボニルー1−メチルビニ・ル)−α−
アミノーα一(4−ヒドロキシフェニル)酢酸ナトリウ
ムを使用して目的化合物24グラムを得た。Example 2 By the same operation as in Example 1, 32 grams of D-N-(
2-methoxycarbonyl-1-methylvinyl)-α-
24 grams of the desired compound were obtained using sodium amino-α-(4-hydroxyphenyl)acetate.
その分析結果は実施例1と同じであつた。実施例3
500m1の容器に35グラムのD−N−(2−エトキ
シカルボニルー1−メチルビニル)−α−アミノーα−
(4−ヒドロキシフェニル)酢酸ナトリウムをとり、2
50m1のN,N−ジメチルアセトアミドを加えて徐々
に冷却し、−10゜Cになつたときこの温度を維持しつ
つ、100m1(7)N,N−ジメチルベンジルアミン
と19グラムのt−ブトキシカルボニルクロライドを加
えて同町温度下1時間半の間反応させる。The analysis results were the same as in Example 1. Example 3 In a 500 ml container, 35 grams of D-N-(2-ethoxycarbonyl-1-methylvinyl)-α-amino-α-
Take sodium (4-hydroxyphenyl)acetate and
Add 50 ml of N,N-dimethylacetamide and slowly cool to -10°C. While maintaining this temperature, add 100 ml (7) of N,N-dimethylbenzylamine and 19 grams of t-butoxycarbonyl. Add chloride and react for 1.5 hours at the same temperature.
別に他の500mLの容器に20グラムの7−アミノデ
スアセトキシセフアロスポラン酸をとり、100m1(
:りN,N−ジメチルアセトアミド及び本発明の新しい
シリル化剤たるN,N−ジメチルートリシリルホルマミ
ジニウムクロライド37グラムを加えて徐々に加温し5
0℃以下の温度で溶解させる。Separately, put 20 grams of 7-aminodesacetoxycephalosporanic acid in another 500 mL container, and add 100 ml (
: Add N,N-dimethylacetamide and 37 grams of N,N-dimethyl-trisilylformamidinium chloride, which is the new silylating agent of the present invention, and gradually warm the mixture.
Dissolve at a temperature below 0°C.
これを冷却した後、先に反応さて得た混合酸無水物の冷
却溶液に適度に加え、−10℃にて2時間攪拌を続ける
。この間適当な有機アミン(ピリジン、トリエチルアミ
ン、ジエチルアミン、ルチジンまたはピコリンなど)を
使用して反応液のPHを6〜7に調節する。反応調節後
100mLの水を加えて一夜攪拌と続けると目的化合物
が粗製結晶状生成物として析出する。After cooling, it is appropriately added to the cooled solution of the mixed acid anhydride obtained by the reaction, and stirring is continued at -10°C for 2 hours. During this time, the pH of the reaction solution is adjusted to 6-7 using a suitable organic amine (pyridine, triethylamine, diethylamine, lutidine, picoline, etc.). After adjusting the reaction, 100 mL of water was added and stirring was continued overnight to precipitate the target compound as a crude crystalline product.
これを枦過してアセトニトリルで洗い、乾燥すると35
グラムの生成物が得られる。本生成物中の目的化合物の
含有量は80%であつた。When this is filtered, washed with acetonitrile, and dried, the
grams of product are obtained. The content of the target compound in this product was 80%.
実施例4
前記実施例3で得られた粗製生成物の結晶を100mt
の水及び200m1のアセトニトリルでスラリー化し、
温度を30〜40℃に温めて希塩酸を徐々に加えると清
澄な溶液となる。Example 4 100 mt of the crude product crystals obtained in Example 3
of water and 200 ml of acetonitrile,
Warming the temperature to 30-40°C and gradually adding diluted hydrochloric acid will result in a clear solution.
Claims (1)
る7−アミノデスアセトキシセアロスポラン酸をシリル
化して、一般式(II): ▲数式、化学式、表等があります▼(II)の如きその酸
のシリルエステルを生成せしめついで一般式(III):
▲数式、化学式、表等があります▼(III)〔ただしR
_1およびR_2は低級アルキル基である〕で表わされ
る混合酸無水物と反応させ該化合物をアシル化した後脱
シリル化することにより一般式(IV):▲数式、化学式
、表等があります▼(IV)で表わされるセフアロスポリ
ン化合物の製造方法において、シリル化剤として一般式
(V): ▲数式、化学式、表等があります▼(V)で表わされる
新規な化合物、N,N−ジメチル−トリメチルシリルホ
ルマジニウムクロライドを使用することを特徴とする前
記セフアロスポリン化合物の改良された製造方法。[Claims] 1 General formula (I): ▲There are mathematical formulas, chemical formulas, tables, etc.▼ 7-aminodesacetoxycearosporanic acid represented by (I) is silylated to form general formula (II): ▲Math. , chemical formulas, tables, etc. ▼ After forming a silyl ester of the acid such as (II), the general formula (III):
▲There are mathematical formulas, chemical formulas, tables, etc.▼(III) [However, R
_1 and R_2 are lower alkyl groups] By reacting with a mixed acid anhydride represented by acylation of the compound and then desilylating it, the general formula (IV): ▲ There are mathematical formulas, chemical formulas, tables, etc. ▼ ( In the method for producing the cephalosporin compound represented by IV), the silylating agent is a novel compound represented by the general formula (V): An improved method for producing the cephalosporin compound, characterized in that maginium chloride is used.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR81-1606 | 1981-05-09 | ||
KR1019810001606A KR820001564B1 (en) | 1981-05-09 | 1981-05-09 | Method for preparing cephalosporin derivative using novel silylating agent |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57185291A JPS57185291A (en) | 1982-11-15 |
JPS6043073B2 true JPS6043073B2 (en) | 1985-09-26 |
Family
ID=19220888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56190944A Expired JPS6043073B2 (en) | 1981-05-09 | 1981-11-30 | Method for producing cephalosporin compounds using new silylating agents |
Country Status (2)
Country | Link |
---|---|
JP (1) | JPS6043073B2 (en) |
KR (1) | KR820001564B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2517127Y2 (en) * | 1987-12-29 | 1996-11-13 | 日本電気ホームエレクトロニクス株式会社 | Horizontal deflection circuit |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004083172A2 (en) * | 2003-03-21 | 2004-09-30 | Ranbaxy Laboratories Limited | Process for the preparation of 7-amino (p-hydroxyphenylglyclyamido) cephem compounds |
WO2006048887A1 (en) * | 2004-11-01 | 2006-05-11 | Hetero Drugs Limited | A novel process for preparation of cefprozil intermediate |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1240687A (en) * | 1967-09-05 | 1971-07-28 | Bristol Myers Co | Antibacterial agents and a process for the preparation thereof |
GB1241844A (en) * | 1968-08-23 | 1971-08-04 | Beecham Group Ltd | Penicillins |
US3985741A (en) * | 1972-09-15 | 1976-10-12 | Bristol-Myers Company | Production of p-hydroxycephalexin |
JPS52125186A (en) * | 1976-04-10 | 1977-10-20 | Teikoku Chem Ind Corp Ltd | Preparation of cephalosporins |
US4160863A (en) * | 1977-04-07 | 1979-07-10 | Bristol-Myers Company | Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid |
US4234721A (en) * | 1976-04-27 | 1980-11-18 | Bristol-Myers Company | Process for the preparation of the crystalline monohydrate of 7-[D-amino-(p-hydroxyphenyl]acetamido)-3-methyl-3-cephen-4-carboxylic acid |
-
1981
- 1981-05-09 KR KR1019810001606A patent/KR820001564B1/en active Pre-grant Review Request
- 1981-11-30 JP JP56190944A patent/JPS6043073B2/en not_active Expired
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1240687A (en) * | 1967-09-05 | 1971-07-28 | Bristol Myers Co | Antibacterial agents and a process for the preparation thereof |
GB1241844A (en) * | 1968-08-23 | 1971-08-04 | Beecham Group Ltd | Penicillins |
US3985741A (en) * | 1972-09-15 | 1976-10-12 | Bristol-Myers Company | Production of p-hydroxycephalexin |
JPS52125186A (en) * | 1976-04-10 | 1977-10-20 | Teikoku Chem Ind Corp Ltd | Preparation of cephalosporins |
US4234721A (en) * | 1976-04-27 | 1980-11-18 | Bristol-Myers Company | Process for the preparation of the crystalline monohydrate of 7-[D-amino-(p-hydroxyphenyl]acetamido)-3-methyl-3-cephen-4-carboxylic acid |
US4160863A (en) * | 1977-04-07 | 1979-07-10 | Bristol-Myers Company | Process for the preparation of the crystalline monohydrate of 7-[D-α-aα-(p-hydroxyphenyl)acetamido]-3-methyl-3-cephem-4-carboxylic acid |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2517127Y2 (en) * | 1987-12-29 | 1996-11-13 | 日本電気ホームエレクトロニクス株式会社 | Horizontal deflection circuit |
Also Published As
Publication number | Publication date |
---|---|
KR820001564B1 (en) | 1982-09-02 |
JPS57185291A (en) | 1982-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4433141A (en) | Intermediate for use in the preparation of cephalosporin antibiotics | |
US20050020561A1 (en) | Process for the preparation of cefpodoxime acid | |
US4148817A (en) | Process and intermediates for preparing cephalosporin antibiotics | |
JPS59130889A (en) | Novel cephalosporin intermediate | |
JPS6043073B2 (en) | Method for producing cephalosporin compounds using new silylating agents | |
US4336376A (en) | Process for the preparation of 7-(D(-)-alpha-amino-p-hydroxyphenylacetamido)desacetoxycephalosporanic acid | |
EP0019067B1 (en) | 5,10-dioxo-5,10-dihydrodiimidazo(1,5-a,1',5'-d)pyrazine-1,6-dicarboxylic acid and a process for producing imidazoledicarboxylic acid amido-derivatives | |
RO109652B1 (en) | PROCEDURE FOR PREPARING AN ANTIBIOTIC CEFEPIM HYDROCHLORIDE DIHYDROCARORIDE | |
JPH0185A (en) | New cephalosporin derivatives | |
JPH025758B2 (en) | ||
JPS5936914B2 (en) | Cephalosporin analogs | |
WO1994002490A1 (en) | Process for producing cephem compound | |
US4182863A (en) | 7-Amino-3-(1-carboxymethyltetrazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid | |
JPH0239519B2 (en) | ||
EP0023045A1 (en) | Imidazolecarboxylic acid derivatives of penicillins and cephalosporins | |
US4223134A (en) | Process for preparing cephalosporin antibiotics | |
KR100472048B1 (en) | Novel method for producing Aztreonam | |
JPS5934199B2 (en) | Bis-trimethylsilylcefamandole and its manufacturing method | |
JP4616844B2 (en) | Production process of intermediates for use in the synthesis of cephalosporin | |
US3868364A (en) | Improved process for producing penicillin compound | |
KR930007816B1 (en) | New Preparation Method of Cefem Compound | |
JPS6183188A (en) | Manufacture of penicillin | |
JPH07165765A (en) | New preparation of cephalosporin derivative | |
JPH043400B2 (en) | ||
KR950013567B1 (en) | Manufacturing Method of Cemfe derivatives |